We are live on ! Find out more
Aspiriant LLC

Aspiriant LLC Portfolio holdings

AUM $4.08B Turnover 21.3%
1-Year Est. Return 12.02%
 

Aspiriant is an employee-owned wealth management firm with accounting roots that pairs financial planning with tax-conscious investing. Formed in 2008 and briefly named Kochis Fitz/Quintile that year, it has since brought together several firms whose client relationships go back many years, in some cases decades. Its investment approach is globally diversified and value-oriented. The firm advises the Aspiriant Affiliated Mutual Funds, which give clients access to private investments. Its clients are mainly high net worth individuals and families, along with professional fiduciaries.

This Fund
S&P 500
This Quarter Est. Return
+0.12%
1 Year Est. Return
+12.02%
3 Year Est. Return
+52.7%
5 Year Est. Return
+47.97%
10 Year Est. Return
+142.06%
AUM
$4.08B
AUM Growth
+$32.7M
Cap. Flow
+$42.9M
Cap. Flow %
1.05%
Top 10 Hldgs %
64.79%
Holding
460
New
60
Increased
185
Reduced
136
Closed
38
Avg Time Held
4.2 years
Top 10 Avg Time Held
6 years
Top 20 Avg Time Held
6.1 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 90.16%
2 Technology 4.02%
3 Financials 1.91%
4 Communication Services 1.2%
5 Healthcare 0.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
UITB icon
151
Victory Portfolios II VictoryShares Core Intermediate Bond ETF
UITB
$2.65B
$1.25M 0.03%
28,000
– –
2026 Q2
1 quarter
EEMV icon
152
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.25B
$1.24M 0.03%
16,741
-2,299
-12% -$170K
2015 Q2
45 quarters
MCK icon
153
McKesson
MCK
$123B
$1.2M 0.03%
1,402
+937
+202% +$806K
2024 Q4
7 quarters
USHY icon
154
iShares Broad USD High Yield Corporate Bond ETF
USHY
$27.6B
$1.17M 0.03%
+32,792
New +$1.2M
2026 Q3
0 quarters
PANW icon
155
Palo Alto Networks
PANW
$296B
$1.17M 0.03%
2,936
-937
-24% -$333K
2023 Q1
14 quarters
BMY icon
156
Bristol-Myers Squibb
BMY
$119B
$1.15M 0.03%
18,399
-179
-1% -$11.3K
2018 Q1
34 quarters
ESGU icon
157
iShares ESG Aware MSCI USA ETF
ESGU
$16.8B
$1.13M 0.03%
6,752
+1,607
+31% +$267K
2025 Q2
5 quarters
VT icon
158
Vanguard Total World Stock ETF
VT
$78.6B
$1.12M 0.03%
7,109
+1,448
+26% +$230K
2020 Q1
26 quarters
DHR icon
159
Danaher
DHR
$160B
$1.12M 0.03%
5,043
+816
+19% +$168K
2016 Q1
42 quarters
NFLX icon
160
Netflix
NFLX
$240B
$1.11M 0.03%
15,940
+968
+6% +$72.7K
2023 Q1
14 quarters
GLD icon
161
SPDR Gold Trust
GLD
$122B
$1.09M 0.03%
2,873
+69
+2% +$27K
2018 Q4
31 quarters
LQD icon
162
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$33B
$1.09M 0.03%
10,691
+51
+0.5% +$5.4K
2025 Q2
5 quarters
USB icon
163
US Bancorp
USB
$89.2B
$1.06M 0.03%
18,433
+96
+0.5% +$5.99K
2016 Q1
42 quarters
GEV icon
164
GE Vernova
GEV
$200B
$1.06M 0.03%
1,118
+35
+3% +$34.7K
2024 Q3
8 quarters
WMT icon
165
Walmart
WMT
$1000B
$1.05M 0.03%
10,108
-4,685
-32% -$514K
2018 Q1
34 quarters
IAU icon
166
iShares Gold Trust
IAU
$54.3B
$1.04M 0.03%
13,274
-194
-1% -$15.6K
2020 Q2
25 quarters
IVE icon
167
iShares S&P 500 Value ETF
IVE
$49.6B
$1.02M 0.03%
4,489
+59
+1% +$13.8K
2021 Q4
19 quarters
KO icon
168
Coca-Cola
KO
$413B
$1.02M 0.03%
11,893
-561
-5% -$48.7K
2018 Q1
34 quarters
LRCX icon
169
Lam Research
LRCX
$255B
$1.02M 0.02%
3,098
+27
+0.9% +$8.43K
2025 Q4
3 quarters
BIL icon
170
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$49.4B
$1.01M 0.02%
+11,000
New +$1.01M
2026 Q3
0 quarters
TMO icon
171
Thermo Fisher Scientific
TMO
$255B
$1M 0.02%
1,486
-38
-2% -$22.6K
2020 Q2
25 quarters
SPCX icon
172
SpaceX
SPCX
$1.88T
$994K 0.02%
+6,590
New +$912K
2026 Q3
0 quarters
DUHP icon
173
Dimensional US High Relative Profitability ETF
DUHP
$12.2B
$994K 0.02%
23,712
+6,413
+37% +$269K
2023 Q1
14 quarters
PFE icon
174
Pfizer
PFE
$157B
$983K 0.02%
34,481
-2,819
-8% -$75K
2016 Q2
41 quarters
QEMM icon
175
State Street SPDR MSCI Emerging Markets StrategicFactors ETF
QEMM
$51.8M
$966K 0.02%
12,022
-70
-0.6% -$5.6K
2018 Q1
34 quarters

Similar funds

Aspiriant LLC's Q3 2026 Portfolio in Review

As of Q3 2026, Aspiriant LLC held 460 positions worth $4.08B, up 0.81% from $4.05B the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Aspiriant LLC's Q3 2026 filing shows 60 new, 185 increased, 136 reduced and 38 closed positions. Its largest new stake was iShares California Muni Bond ETF: 47,237 shares worth $2.56M. The largest sale was Dimensional US Core Equity 2 ETF, an estimated $14.2M.

By sector, the portfolio is most concentrated in Miscellaneous at 90% of assets, down from 90% a quarter earlier, followed by Technology and Financials.

  • Aspiriant LLC's largest Q3 2026 buy was iShares California Muni Bond ETF: 47,237 shares worth $2.56M.
  • Aspiriant LLC added most to iShares Core S&P 500 ETF in Q3 2026, an estimated $19.6M increase.
  • Aspiriant LLC's biggest Q3 2026 reduction was Vanguard S&P Small-Cap 600 Value ETF, cutting an estimated $2.25M.
  • Aspiriant LLC fully exited Dimensional US Core Equity 2 ETF in Q3 2026, selling an estimated $14.2M.
  • Aspiriant LLC's ten largest holdings make up 65% of its $4.08B portfolio in Q3 2026.
  • Aspiriant LLC opened 60 new positions and closed 38 in Q3 2026.
  • Aspiriant LLC's portfolio value rose 0.81% quarter-over-quarter to $4.08B.

Based on Aspiriant LLC's 13F filing for Q3 2026, filed 16 Oct 2026.